Cargando…

Useful Test for Classification of Cerebral Infarction at Hospital Specializing in Neurosurgery

Background and Purpose: There are many cases of cerebral infarction of unknown etiology in which the embolic sources cannot be identified including atrial fibrillation despite achievement of complete revascularization after thrombectomy. Method: An analysis was conducted for 556 consecutive cases of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Hirotaka, Nishitani, Kazutoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese College of Angiology / The Japanese Society for Vascular Surgery / Japanese Society of Phlebology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816022/
https://www.ncbi.nlm.nih.gov/pubmed/36644253
http://dx.doi.org/10.3400/avd.oa.22-00099
_version_ 1784864435941146624
author Yoshida, Hirotaka
Nishitani, Kazutoshi
author_facet Yoshida, Hirotaka
Nishitani, Kazutoshi
author_sort Yoshida, Hirotaka
collection PubMed
description Background and Purpose: There are many cases of cerebral infarction of unknown etiology in which the embolic sources cannot be identified including atrial fibrillation despite achievement of complete revascularization after thrombectomy. Method: An analysis was conducted for 556 consecutive cases of patients who were hospitalized for cerebral infarction to determine the significance of accurate classification of disease type and investigation into causes of cerebral infarction of unknown cause. Result: According to the Trials of Org 10172 in Acute Stroke Treatment (TOAST) classification, cerebral infarction of other/unknown etiology was observed in 94 cases, of which 22 cases were found to have causes by additional workup. Implantable cardiac monitors were inserted in 15 of 76 cases of cryptogenic cerebral infarction, of which 4 cases (26%) showed detection of paroxysmal atrial fibrillation (PAF) during observation period (223–384 days). Conclusion: Brain natriuretic peptide (BNP) measurement, abdomen-pelvic computed tomography (CT), cardiac monitoring for 1 week, and implantable cardiac monitors (ICM) were useful for the classification of disease type and detection of cryptogenic atrial fibrillation. (This is secondary publication from J Jpn Coll Angiol 2021; 61: 49–55.)
format Online
Article
Text
id pubmed-9816022
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Japanese College of Angiology / The Japanese Society for Vascular Surgery / Japanese Society of Phlebology
record_format MEDLINE/PubMed
spelling pubmed-98160222023-01-12 Useful Test for Classification of Cerebral Infarction at Hospital Specializing in Neurosurgery Yoshida, Hirotaka Nishitani, Kazutoshi Ann Vasc Dis Original Article Background and Purpose: There are many cases of cerebral infarction of unknown etiology in which the embolic sources cannot be identified including atrial fibrillation despite achievement of complete revascularization after thrombectomy. Method: An analysis was conducted for 556 consecutive cases of patients who were hospitalized for cerebral infarction to determine the significance of accurate classification of disease type and investigation into causes of cerebral infarction of unknown cause. Result: According to the Trials of Org 10172 in Acute Stroke Treatment (TOAST) classification, cerebral infarction of other/unknown etiology was observed in 94 cases, of which 22 cases were found to have causes by additional workup. Implantable cardiac monitors were inserted in 15 of 76 cases of cryptogenic cerebral infarction, of which 4 cases (26%) showed detection of paroxysmal atrial fibrillation (PAF) during observation period (223–384 days). Conclusion: Brain natriuretic peptide (BNP) measurement, abdomen-pelvic computed tomography (CT), cardiac monitoring for 1 week, and implantable cardiac monitors (ICM) were useful for the classification of disease type and detection of cryptogenic atrial fibrillation. (This is secondary publication from J Jpn Coll Angiol 2021; 61: 49–55.) Japanese College of Angiology / The Japanese Society for Vascular Surgery / Japanese Society of Phlebology 2022-12-25 /pmc/articles/PMC9816022/ /pubmed/36644253 http://dx.doi.org/10.3400/avd.oa.22-00099 Text en © 2022 The Editorial Committee of Annals of Vascular Diseases. https://creativecommons.org/licenses/by/2.5/This article is distributed under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided the credit of the original work, a link to the license, and indication of any change are properly given, and the original work is not used for commercial purposes. Remixed or transformed contributions must be distributed under the same license as the original.
spellingShingle Original Article
Yoshida, Hirotaka
Nishitani, Kazutoshi
Useful Test for Classification of Cerebral Infarction at Hospital Specializing in Neurosurgery
title Useful Test for Classification of Cerebral Infarction at Hospital Specializing in Neurosurgery
title_full Useful Test for Classification of Cerebral Infarction at Hospital Specializing in Neurosurgery
title_fullStr Useful Test for Classification of Cerebral Infarction at Hospital Specializing in Neurosurgery
title_full_unstemmed Useful Test for Classification of Cerebral Infarction at Hospital Specializing in Neurosurgery
title_short Useful Test for Classification of Cerebral Infarction at Hospital Specializing in Neurosurgery
title_sort useful test for classification of cerebral infarction at hospital specializing in neurosurgery
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816022/
https://www.ncbi.nlm.nih.gov/pubmed/36644253
http://dx.doi.org/10.3400/avd.oa.22-00099
work_keys_str_mv AT yoshidahirotaka usefultestforclassificationofcerebralinfarctionathospitalspecializinginneurosurgery
AT nishitanikazutoshi usefultestforclassificationofcerebralinfarctionathospitalspecializinginneurosurgery